In this review:
Circadian rhythm and intestinal function in IBD
Early combined immunosuppression in CD
IBD treatment costs in the biological era
Endoscopic resection of dysplasia in UC
Long-term safety and efficacy of golimumab in UC
Cancer risk in Dutch UC patients
Optimising post-operative CD management: The POCER study
Malignancies in CD: The ENCORE registry
HRQoL after intestinal resection in POCER
Smartphone apps for IBD
IBD activity assessment by e-health technologies
Web-guided therapy in UC
Feasibility of a telemedicine tool in the Netherlands
Mucosal microbiota in siblings of CD patients
Please login below to download this issue (PDF)